Biotechnology

Anthropic says its AI model Claude discovered a CRISPR-like enzyme system, alongside a CEO claim that AI could cure most major diseases within a decade.

9 sources 9 articles v 7 25d ago

◼ Archived Health 🔮 fades ✓

Performance and safety of a multi-cancer early detection test: the PATHFINDER 2 study

Blood test detects more cancers when added to standard screening

8 sources 8 articles v 6 26d ago

◼ Archived Business 🔮 fades ✓

Amgen’s Horizon-acquired fusion protein eases Sjögren's severity in ph. 3 win

10 news sources are covering this Business story right now — Archynetys is tracking how fast it spreads.

10 sources 10 articles v 8 26d ago

◼ Archived Business 🔮 fades ✓

Radiopharma companies merge after one receives surprise FDA rejection

6 news sources are covering this Business story right now — Archynetys is tracking how fast it spreads.

6 sources 6 articles v 4 28d ago

◼ Archived Business 🔮 fades ✓

FDA approves a new gene therapy for Sanfilippo syndrome, an ultra-rare disease

8 news sources are covering this Business story right now — Archynetys is tracking how fast it spreads.

8 sources 9 articles v 6 31d ago

◼ Archived Business 🔮 fades ✓

Novo explores macrocycles’ potential in $1.4B cardiometabolic pact with Danish biotech

Novo Nordisk has signed an up to $1.4 billion licensing deal with Danish biotech Orbis Medicines to develop oral macrocycle drugs for cardiometabolic diseases.

6 sources 6 articles v 4 32d ago

◼ Archived Science 🔮 fades ✓

A microprotein atlas of the human frontal cortex in Alzheimer’s disease

A fresh atlas of microproteins in the Alzheimer’s‑affected frontal cortex opens a new frontier for drug discovery.

5 sources 6 articles v 3 34d ago

◼ Archived Science 🔮 fades ✓

Decades-old DNA mystery solved after strands are captured zipping together for the first time

Scientists have captured DNA strands zipping together for the first time, solving a decades-old mystery of how molecules overcome repulsion to pair up.

5 sources 5 articles v 3 38d ago

◼ Archived Health 🔮 fades ✓

How AI makes biological research more dangerous

AI speeds biotech breakthroughs while heightening the risk of engineered pathogens, prompting urgent calls for safety safeguards.

9 sources 9 articles v 7 38d ago

◼ Archived Business 🔮 fades ✓

Novartis cholesterol setback tests hopes for emerging heart disease drugs

Novartis' cholesterol drug fails critical cardiovascular test, casting doubt on multibillion-dollar heart disease drug race.

4 sources 6 articles v 3 41d ago

◼ Archived Business 🔮 fades ✓

ARPA-H awards $125M for manufacturing custom RNA therapies on demand

The US government is investing heavily in on-demand RNA therapies, but the path to market is not straightforward.

9 sources 9 articles v 7 47d ago

◼ Archived Science

Scientists get 2 genetic codes working in one cell, a step toward life built with novel proteins

Scientists have engineered cells to use two genetic codes simultaneously, expanding the range of possible proteins.

4 sources 4 articles v 2 48d ago

◼ Archived Business 🔮 fades ✓

Eli Lilly inks $2.88B Merida buyout for autoimmune drugs against rogue antibodies

Eli Lilly's $2.88 billion acquisition of Merida Biosciences is poised to reshape the autoimmune disease treatment landscape.

8 sources 9 articles v 6 48d ago

◼ Archived Business 🔮 fades ✓

Roche pens $2.5B pact for Hanmi’s clinical-stage obesity drug targeting less-explored mechanism

Roche’s $2.5 billion pact for Hanmi’s muscle‑sparing obesity drug ignites expectations for a new weight‑loss breakthrough

8 sources 8 articles v 6 55d ago

◼ Archived Business 🔮 fades ✓

FDA Approves Alzheimer’s Blood Test Developed by Roche and Eli Lilly

The FDA has granted clearance for the first blood-based biomarker test for Alzheimer's disease, developed through a partnership between Roche and Eli Lilly.

15 sources 15 articles v 15 55d ago

◼ Archived Health 🔮 fades ✓

Oldest human brain cells grown in lab 'recorded passage of time'

Lab-grown human brain cells have recorded the passage of time for seven years, challenging assumptions about their longevity and capabilities.

9 sources 9 articles v 7 55d ago

◼ Archived Health 🔮 fades ✓

Smart probiotics can sense high blood sugar and release GLP-1 on demand

A new probiotic can sense high blood sugar and release a diabetes drug on demand, potentially revolutionizing treatment.

5 sources 5 articles v 14 57d ago

◼ Archived Business

How a Big Bet on Cancer Vaccines Brought Moderna Back from the Brink

Moderna's cancer vaccine trials could transform treatment, but the math is still out.

4 sources 5 articles v 3 57d ago

◼ Archived Health 🔮 fades ✓

New ROOT method charts a path to reversing biological changes once thought irreversible

A new technique from KAIST may reverse aging and cancer by reprogramming cells thought to be permanently altered.

5 sources 5 articles v 3 58d ago

◼ Archived Science 🔮 fades ✓

New lipid nanoparticle delivers capped circular RNA for longer-lasting gene expression

A new lipid nanoparticle promises to extend the duration of gene expression, potentially revolutionizing RNA therapies.

5 sources 5 articles v 3 59d ago

◼ Archived Business 🔮 fades ✓

After Moderna stock surge of 177% on cancer drug breakthrough, here's what Wall Street thinks happens next

Moderna's stock surge on a cancer drug breakthrough has Wall Street abuzz with speculation about the future of cancer treatment.

6 sources 7 articles v 4 60d ago

◼ Archived Health 🔮 fades ✓

Scientists just discovered a big limitation in lab-grown minibrains

Lab-grown minibrains have reached a longevity milestone, but scientists have found a major limitation.

4 sources 4 articles v 2 60d ago

◼ Archived Business 🔮 fades ✓

Moderna Shares Double on Success of mRNA Cancer Vaccine

Moderna's shares have doubled since August 19th, 2026, as investors react to a breakthrough in cancer treatment.

6 sources 6 articles v 6 60d ago

◼ Archived Health 🔮 fades ✓

A pill that mimics exercise? Early results on drug designed to maintain both weight loss and muscle mass

A drug designed to mimic exercise has passed its first human test, sparking interest in the medical community.

9 sources 9 articles v 7 58d ago

◼ Archived Business

Exclusive: Third death in China's popular but opaque trials revealed, this time in CAR-T

A third death in China's gene therapy trials raises questions about the safety and oversight of these experimental treatments.

5 sources 5 articles v 14 62d ago

◼ Archived Health 🔮 fades ✓

The use of AI in biotechnology is changing faster than the rules governing either technology

Functioning viruses are now being designed from scratch using AI, sparking urgent debates over the intersection of biotechnology and global biosecurity protocols.

6 sources 6 articles v 4 61d ago

◼ Archived Health 🔮 fades ✓

Chinese team aims to put ‘smart’ diabetes probiotic on US shelves within 2 years

A Chinese team is racing to bring a 'smart' probiotic for diabetes to the US market.

5 sources 5 articles v 3 62d ago

◼ Archived Health 🔮 fades ✓

How to build an AI-driven digital organism

Scientists are racing to build AI-driven digital organisms to test drugs before human trials

5 sources 5 articles v 3 65d ago

◼ Archived Health

Scientists turn sheep’s wool into a material that helps regrow bone

A new bone-regeneration material derived from sheep's wool is under investigation for its potential in orthopedic medicine.

4 sources 4 articles v 2 67d ago

◼ Archived Business 🔮 fades ✓

RK Mellon Foundation pledges $25M to launch rare disease therapy hub in Pittsburgh - Pittsburgh Post-Gazette

The RK Mellon Foundation's $25M investment aims to transform Pittsburgh into a hub for rare disease therapies.

5 sources 5 articles v 14 68d ago

◼ Archived Business 🔮 fades ✓

AI brings savings to clinical trials: study

Research indicates AI integration could deliver 82 times the return on investment in oncology clinical trials while reshaping the drug development market.

9 sources 9 articles v 7 67d ago

◼ Archived Business 🔮 fades ✓

Regeneron backs $75M series A for antibody upstart Infinimmune

Alameda-based biotech Infinimmune has secured $75 million in Series A funding to advance its antibody pipeline for atopic dermatitis and inflammatory diseases.

7 sources 7 articles v 5 68d ago

◼ Archived Business 🔮 fades ✓

Silence Therapeutics aims at Takeda with new data in rare blood cancer

Silence Therapeutics' new data on a rare blood cancer drug could disrupt Takeda's market position.

7 sources 7 articles v 5 70d ago

◼ Archived Health 🔮 fades ✓

Stanford AI virus study raises specter of bioweapon risk

A Stanford study has used AI to create 16 new viruses that never existed in nature, raising concerns about bioweapon risks.

5 sources 6 articles v 3 71d ago

◼ Archived Health 🔮 fades ✓

AI creates first synthetic viruses

For the first time, AI has designed viruses that do not exist in nature.

11 sources 12 articles v 10 72d ago

◼ Archived Health 🔮 fades ✓

Experimental Cancer Drug Force-Feeds Tumors Sugar Until They Choke

A newly developed covalent PFKL activator forces cancer cells to consume excess sugar, effectively stuntng tumor growth through metabolic overload.

9 sources 9 articles v 7 73d ago

◼ Archived Health 🔮 fades ✓

Stimulation modulates gene-linked cell assemblies in the human brain

Researchers have discovered how electrical stimulation affects neurons and gene activity in living human brain tissue.

8 sources 8 articles v 6 74d ago

◼ Archived Science 🔮 fades ✓

Gene-edited beagles may offer a future option for people with dog allergies

Kindred Companion Sciences has unveiled the world's first beagles genetically edited via CRISPR to remove the protein responsible for triggering dog allergies.

24 sources 25 articles v 31 70d ago

◼ Archived Health 🔮 fades ✓

Cancer-fighting antibodies with a one-two punch take aim at tumours

Engineered bispecific antibodies are targeting B-cell lymphoma by simultaneously engaging tumor cells and activating macrophages to destroy them.

5 sources 5 articles v 3 76d ago

◼ Archived Health

Self-moving, self-cloning sponge could restore degraded harbours

Researchers are deploying Chondrosia reniformis sponges in polluted marinas to evaluate their capacity for self-replication and environmental cleanup.

5 sources 5 articles v 3 80d ago

◼ Archived Technology 🔮 fades ✓

Breathalyser can tell if you are burning fat from a single exhalation

6 news sources are covering this Technology story right now — Archynetys is tracking how fast it spreads.

6 sources 6 articles v 4 87d ago

◼ Archived Health 🔮 fades ✗

Engineered enzyme erases a stubborn mark of aging by up to 70% in human tissue samples

Engineered enzymes are being utilized to reverse molecular protein damage in human tissue samples, potentially addressing a biological marker of aging.

7 sources 7 articles v 5 88d ago

◼ Archived Science 🔮 fades ✗

MIT Scientists Grew Artificial Blood Vessels In The Lab Using Magnets

MIT engineers have developed a method to grow and redirect artificial blood vessels using magnetic fields and mechanical stretching.

9 sources 9 articles v 7 89d ago

◼ Archived Technology 🔮 fades ✓

Wooly Mammoth startup Colossal seeking at least $20B valuation

De-extinction startup Colossal Biosciences is reportedly seeking a valuation between $20 billion and $30 billion in a new funding round.

5 sources 5 articles v 3 91d ago

◼ Archived Science 🔮 fades ✓

Plants that make real dairy protein? Scientists discover an unexpected shortcut

Scientists have unlocked a biotechnological shortcut allowing plants to produce bovine casein, a key dairy protein, without the need for cows.

5 sources 5 articles v 3 92d ago

◼ Archived Technology 🔮 fades ✓

Which ‘AI scientist’ suits your lab? A guide for the perplexed

Anthropic has launched a dedicated research workbench for oncology and drug discovery, prompting broad analysis of AI integration in scientific laboratories.

5 sources 5 articles v 3 101d ago

◼ Archived Health 🔮 fades ✓

The data that led an AI biotech to pick up Novo's Parkinson's stem cell therapy

An AI biotech firm has acquired Novo's Parkinson's stem cell therapy following promising results from the first human trials.

6 sources 6 articles v 4 100d ago

◼ Archived Business 🔮 fades ✓

'We're paranoid.' As China biotech competition heats up, American drugmakers get more secretive

6 news sources are covering this Business story right now — Archynetys is tracking how fast it spreads.

6 sources 6 articles v 4 101d ago

◼ Archived Science 🔮 fades ✗

'Mitch' protein that could change the future of weight loss and fat burning

Researchers have identified a protein called 'Mitch' that regulates fat storage and energy usage in cells.

5 sources 5 articles v 3 100d ago

◼ Archived Science 🔮 fades ✓

Non-genotoxic transplantation and in vivo selection through epitope editing

4 news sources are covering this Science story right now — Archynetys is tracking how fast it spreads.

4 sources 4 articles v 2 102d ago

◼ Archived Health 🔮 fades ✓

The First AI‑Designed Vaccine Has Been Tested in People. Here’s What Happened.

Clinical trials for the world's first AI-designed vaccine have entered human testing, marking a potential shift in medical development methodology.

4 sources 4 articles v 2 103d ago

◼ Archived Business 🔮 fades ✓

MeiraGTx scores $400M from Oberland Capital to help get 2 gene therapies to commercialization

MeiraGTx has secured significant new funding from Oberland Capital to advance two gene therapies toward commercialization.

5 sources 5 articles v 3 103d ago

What Archynetys tracks about Biotechnology